Cargando…
Sclerostin as a biomarker of cardiovascular risk in women with systemic lupus erythematosus
Cardiovascular disease is one of the main causes of death in patients with systemic lupus erythematosus (SLE). On the other hand, sclerostin is a reliable and early biomarker of vascular calcification. This study aimed to estimate the association between sclerostin and two markers of cardiovascular...
Autores principales: | Garcia-de los Ríos, Carlos, Medina-Casado, Marta, Díaz-Chamorro, Antonio, Sierras-Jiménez, María, Lardelli-Claret, Pablo, Cáliz-Cáliz, Rafael, Sabio, José Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749620/ https://www.ncbi.nlm.nih.gov/pubmed/36517533 http://dx.doi.org/10.1038/s41598-022-25651-y |
Ejemplares similares
-
Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
por: Hernández-Cruz, Blanca, et al.
Publicado: (2016) -
Sclerostin and Cardiovascular Disease
por: Tobias, Jonathan H.
Publicado: (2023) -
Physical Fitness and Body Composition in Women with Systemic Lupus Erythematosus
por: Sola-Rodríguez, Sergio, et al.
Publicado: (2019) -
Biomarkers in DILI: One More Step Forward
por: Robles-Díaz, Mercedes, et al.
Publicado: (2016) -
El contrato de trabajo, una garantía social para los trabajadores
por: Caliz Tiburcio, Manuel
Publicado: (2006)